M. G. Cabras

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study

Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci et al. · Haematologica · 2009 · 65 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma

Francesco Zaja, Valentina Tomadini, Alfonso Zaccaria et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 59 citations

Medicine, Hematology, Oncology +16

Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas

Roberto Santi, Manuela Ceccarelli, Elisa Bernocco et al. · Thrombosis and Haemostasis · 2017 · 38 citations · Full text

Medicine, Hematology, Oncology +17

Short-course R-CHOP followed by 90Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results

Vittorio Stefoni, Beatrice Casadei, Chiara Bottelli et al. · Blood Cancer Journal · 2016 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL

Maurizio Martelli, Emanuele Zucca, Barbara Botto et al. · Hematological Oncology · 2021 · 13 citations · Full text

Medicine, Nuclear Medicine, Oncology +17